INNOVATIVE PHAR(00399): Subscription agreement terminated
Leading Pharmaceuticals Biotechnology (00399) announced that a maximum of 1... each at the subscription price of HK$0.415 per share.
INNOVATIVE PHAR (00399) announced that the sale agreement to sell up to 145 million shares of the company at a sale price of HK$0.415 per share has become invalid as the conditions precedent specified in the sale agreement were not met by September 11, 2025. The sale agent and the company's obligations under the sale agreement are terminated and any party to the agreement cannot make any claims against the other party regarding the sale agreement.
Related Articles
YGM TRADING (00375) plans to sell all of its issued shares in YGM Retail.
.png)
YGM TRADING (00375) suggests reducing share capital.
SHENZHENEXPRESS (00548) has been approved to issue 5 billion yuan worth of medium-term notes.
YGM TRADING (00375) plans to sell all of its issued shares in YGM Retail.
YGM TRADING (00375) suggests reducing share capital.
SHENZHENEXPRESS (00548) has been approved to issue 5 billion yuan worth of medium-term notes.
RECOMMEND
Hong Kong Stock Concept Tracker｜Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025
Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025
Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025
